Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients

doi:10.4254/wjh.v12.i11.1076

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6313)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

343

WORD

176

HTML

2432

Figures (1-5)

250

Tables (1-2)

234

Sum=3435

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

260

Download

882

Sum=1142

Publishing Process of This Article

Item

Count

Browse

532

Download

1204

Sum=1736

Nov 27, 2020 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Hepatol. Nov 27, 2020; 12(11): 1076-1088
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.1076

Full Size Figure Download Figure

Figure 4 Linear regression model of hepatitis B surface antigen levels according to treatment group. NA: Nucleos(t)ids analogue; Peg-IFN: Pegylated interferon; LR: Linear regression.

Citation: Broquetas T, Garcia-Retortillo M, Micó M, Canillas L, Puigvehí M, Cañete N, Coll S, Viu A, Hernandez JJ, Bessa X, Carrión JA. Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients. World J Hepatol 2020; 12(11): 1076-1088
URL: https://www.wjgnet.com/1948-5182/full/v12/i11/1076.htm
DOI: https://dx.doi.org/10.4254/wjh.v12.i11.1076